comparemela.com
Home
Live Updates
Rome Therapeutics adds $72 million to Series B round to harness dark genome : comparemela.com
Rome Therapeutics adds $72 million to Series B round to harness "dark genome"
The U.S. company Rome Therapeutics plans to use the proceeds of its $72 million Series B round to take an experimental autoimmune disease treatment through early clinical testing.
Related Keywords
Rome ,
Lazio ,
Italy ,
United Kingdom ,
Enara Bio ,
Rosana Kapeller ,
Bristol Myers Squibb ,
Johnson ,
Boehringer Ingelheim ,
Sanofi Ventures ,
Nucleome Therapeutics ,
Markets Amp Regulations ,
Clinical Development ,
Linical Evolution ,
Seriesb Funding Round ,
Enome ,
Gene Therapy ,
comparemela.com © 2020. All Rights Reserved.